Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
measles and rubella vaccine (Serum Institute of India)
- Development stage
- Phase 2
- Lead developer
- Serum Institute of India
- Modality
- Live Attenuated Vaccines → Live Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Administration
- Subcutaneous, Intramuscular (occasionally Used)
01
Overview
The measles and rubella vaccine is a combination vaccine containing live, attenuated (weakened) strains of both the measles virus and the rubella virus. It is designed to induce immunity against both diseases by stimulating the body’s immune system to produce protective antibodies. The mechanism of action involves exposure to these weakened viruses, which do not cause disease in healthy individuals but prompt an immune response that results in long-lasting protection. The primary indication for this vaccine is the prevention of measles and rubella infections, both of which are highly contagious viral diseases with potentially serious complications. This combination may be used alone or as part of broader vaccines such as MMR (measles, mumps, and rubella), but specifically refers here only to formulations containing just measles and rubella components.
- Other names
- measles-rubella vaccineMR vaccine
Beyond the preview
Go deeper on measles and rubella vaccine (Serum Institute of India).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on measles and rubella vaccine (Serum Institute of India).